Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2008-05-20
2008-05-20
Eyler, Yvonne (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C514S521000, C514S562000, C548S410000
Reexamination Certificate
active
10561055
ABSTRACT:
Compounds of formula (I):whereinR1represents optionally substituted C4-12alkyl, optionally substituted C2-6alkylaryl, or optionally substituted 5- or 6-membered aryl or heteroaryl;Z represents a bond, CH2, O, S, SO, SO2, NR4, OCR4R5, CR4R5O, or Z, R1and Q together form an optionally substituted fused tricyclic group;Q represents an optionally substituted 5- or 6-membered aryl or heteroaryl ring;X represents COR3or N(OR8)COR9;R2represents SO2R10or SO2NR10R11;R3represents OR6, NR6R7or NR6OH;R4and R5each independently represents H, C1-6alkyl or C1-4alkylaryl;R6and R7each independently represents H, C1-6alkyl, or C1-6alkyl substituted with one or more heteroaryl groups, or R6and R7together with the nitrogen atom to which they are attached form a 5- or 6-membered ring which may optionally include 1 or more further heteroatoms selected from O, S and N;R8and R9each independently represents H or C1-6alkyl;R10and R11each independently represents H or C1-6alkyl; andand physiologically functional derivatives thereof, with the exception of N-(ethoxycarbonyl)-N-[4-(1H-tetrazol-1-yl)phenyl]glycine, processes for their preparation, pharmaceutical formulations containing them and their use as inhibitors of matrix metalloproteinase enzymes (MMPs) are described.
REFERENCES:
patent: 5710171 (1998-01-01), Dinsmore et al.
patent: 5736487 (1998-04-01), Sugai et al.
patent: 5852192 (1998-12-01), Himmelsbach et al.
patent: 6451832 (2002-09-01), Ries et al.
patent: 6593355 (2003-07-01), Ries et al.
patent: 6720424 (2004-04-01), Wada et al.
patent: 6897237 (2005-05-01), Hori et al.
patent: 2001/0006977 (2001-07-01), Ries et al.
patent: 2003/0004356 (2003-01-01), Ries et al.
patent: 2003/0158155 (2003-08-01), Hori et al.
patent: 2624094 (1975-05-01), None
patent: 2002/193800 (2000-12-01), None
patent: WO96/27583 (1996-09-01), None
patent: WO 03035610 (2001-10-01), None
patent: WO 02/083642 (2002-10-01), None
Chemical Abstract Service, Jul. 9, 2002, Abstract No. XP002305420.
Database WPI, Section Ch, Week 199951, Aug. 31, 1999, Abstract No. XP002305421.
Database Caplus, Kuragano, Takashi et al., Chemical Abstract Service, May 16, 2002, Abstract No. XP002305419.
Ichikawa, T. et al., Chem. Pharma. Bull., 2001, 49(9), pp. 1110-1119.
Munshi, A.A., Trivedi, J.P., J. Indian Chem. Soc., 1966, 43(4), pp. 277-8.
Holmes Ian
Watson Stephen Paul
Eyler Yvonne
Glaxo Group Limited
Hsu Grace C.
Kinzig Charles M.
Lao MLouisa
LandOfFree
Inhibitors of matrix metalloproteinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of matrix metalloproteinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of matrix metalloproteinase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3927694